Clinical Trial Update: Effect of Mavacamten Treatment on Coronary Flow Reserve in oHCM

View source ↗

Summary

Clinical trial update for mavacamten in obstructive hypertrophic cardiomyopathy. The study investigates the effect on coronary flow reserve and is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Hypertrophic Cardiomyopathy

Drugs mentioned

• CAMZYOS (MAVACAMTEN)

Snippet

Sponsor: Michael Ayers | Conditions: Obstructive Hypertrophic Cardiomyopathy | Status: RECRUITING